Dianthus Therapeutics DNTH
NASDAQ DNTH
$88.21 -0.11 (-0.12%)
At close: Oct 2, 2026 · 4:00 PM EDT

Dianthus Therapeutics (DNTH) Gains from Sales and Divestitures (2018 - 2023)

Updated

Dianthus Therapeutics (DNTH) recorded Gains from Sales and Divestitures of $32,000 in Q2 2023.

Analysis

Dianthus Therapeutics (DNTH) Gains from Sales and Divestitures (2018 - 2023) Analysis & Trends

On a TTM basis, Dianthus Therapeutics' Gains from Sales and Divestitures came in at -$3.32 million as of Jun 30, 2023; for FY2021, it was -$95,000.

  • Across earlier years, Gains from Sales and Divestitures came in at -$1,000 in FY2020 and -$67,000 in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Dianthus Therapeutics 3.78 Bn 3.73 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 32,000.00
Mar 31, 2023 -3.36 Mn
Sep 30, 2021 -5,000.00
Mar 31, 2021 -90,000.00
Sep 30, 2018 -65,000.00
API Access

Dianthus Therapeutics Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=DNTH&period=max&api_key=YOUR_API_KEY